	A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial. CNS Drugs Kane JM, Eshet R, Harary E, Tohami O, Elgart A, Knebel H, Sharon N, Suett M, Franzenburg KR, Davis GL 3rd, Correll CU. PMID: 38954317 [PubMed - as supplied by publisher]
	We like to move it - patients with schizophrenia spectrum disorders are impaired in estimating their physical fitness levels and benefit from individualized exercise. Eur Arch Psychiatry Clin Neurosci Rippe W, Weisner L, Ewen J, Mench P, Koppius T, Borgwardt S, Tari B, Heath M, Sprenger A, Wilms B, Lencer R. PMID: 38953981 [PubMed - as supplied by publisher]
	Identification of schizophrenia by applying interpretable radiomics modeling with structural magnetic resonance imaging of the cerebellum. Psychiatry Clin Neurosci Bang M, Park K, Choi SH, Ahn SS, Kim J, Lee SK, Park YW, Lee SH. PMID: 38953397 [PubMed - as supplied by publisher]
	Understanding Cognitive Behavioral Therapy for Psychosis Through the Predictive Coding Framework. Biol Psychiatry Glob Open Sci Sheffield JM, Brinen AP, Feola B, Heckers S, Corlett PR. PMID: 38952435 [PubMed]
	Whole-exome sequencing of individuals from an isolated population under extreme conditions implicates rare risk variants of schizophrenia. Transl Psychiatry Chen L, Du Y, Hu Y, Li XS, Chen Y, Cheng Y. PMID: 38951484 [PubMed - indexed for MEDLINE]
	When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis. CNS Drugs Qubad M, Dupont G, Hahn M, Martin SS, Puntmann V, Nagel E, Reif A, Bittner RA. PMID: 38951464 [PubMed - as supplied by publisher]
	Diagnostic shift in adolescents with first episode psychosis: findings from the 2-year follow-up of the "Parma Early Psychosis" program. Soc Psychiatry Psychiatr Epidemiol Pelizza L, Plazzi E, Leuci E, Leucci AC, Quattrone E, Azzali S, Pupo S, Paulillo G, Pellegrini P, Menchetti M. PMID: 38951155 [PubMed - as supplied by publisher]
	Improving processing speed in adolescents at clinical high risk for psychosis with the Specific COgnitive REmediation plus Surround (SCORES) intervention: Study protocol. Early Interv Psychiatry Carrión RE, Auther AM, McLaughlin D, John M, Cornblatt BA. PMID: 38951112 [PubMed - as supplied by publisher]
	Schizophrenia interactome derived repurposable drugs and randomized control trials of two candidates. Biol Psychiatry Ganapathiraju MK, Triptish B, Deshpande S, Wesesky M, Wood J, Nimgaonkar VL. PMID: 38950808 [PubMed - as supplied by publisher]
	Static and Dynamic Cross-Network Functional Connectivity Shows Elevated Entropy in Schizophrenia Patients. bioRxiv Maksymchuk N, Bustillo JR, Mathalon DH, Preda A, Calhoun VD. PMID: 38948857 [PubMed]
	A deep learning approach for diagnosis of schizophrenia disorder via data augmentation based on convolutional neural network and long short-term memory. Biomed Eng Lett Shams AM, Jabbari S. PMID: 38946814 [PubMed]
	Applications of MRI in Schizophrenia: Current Progress in Establishing Clinical Utility. J Magn Reson Imaging Sun H, Liu N, Qiu C, Tao B, Yang C, Tang B, Li H, Zhan K, Cai C, Zhang W, Lui S. PMID: 38946400 [PubMed - as supplied by publisher]
	Clinical Pipelines for Alzheimer's Disease Psychosis and Agitation. Chem Pharm Bull (Tokyo) Oguma T, Jino K. PMID: 38945937 [PubMed - indexed for MEDLINE]
	Clinical, cognitive, and functional characteristics of recent-onset psychosis with autistic features: A 2-year longitudinal study. Schizophr Res Jeong JH, Kim SW, Yu JC, Won SH, Lee SH, Kim SH, Kang SH, Kim E, Chung YC, Lee KY. PMID: 38944977 [PubMed - as supplied by publisher]
	The association of prolactin and gonadal hormones with cognition and symptoms in men with schizophrenia spectrum disorder: Divergent effects of testosterone and estrogen. Schizophr Res Hamers IMH, Brand BA, Begemann MJH, Weickert CS, Weickert TW, Sommer IEC. PMID: 38944973 [PubMed - as supplied by publisher]
	Early efficacy of rTMS intervention at week 2 predicts subsequent responses at week 24 in schizophrenia in a randomized controlled trial. Neurotherapeutics Ye S, Guan X, Xiu M, Wu F, Huang Y. PMID: 38944636 [PubMed - as supplied by publisher]
	INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia. Schizophr Res Murthy V, Hanson E, DeMartinis N, Asgharnejad M, Dong C, Evans R, Ge T, Dunayevich E, Singh JB, Ratti E, Galderisi S. PMID: 38943928 [PubMed - as supplied by publisher]
	Minor physical anomalies in schizophrenia and first-degree relatives in comparison to healthy controls: A systematic review and meta-analysis. Eur Neuropsychopharmacol Sut E, Akgül Ö, Bora E. PMID: 38943776 [PubMed - as supplied by publisher]
	Mesostriatal Dopaminergic Circuit Dysfunction in Schizophrenia: A Multimodal Neuromelanin-sensitive MRI and [18F]-DOPA PET Study. Biol Psychiatry Vano LJ, McCutcheon RA, Rutigliano G, Kaar SJ, Finelli V, Nordio G, Wellby G, Sedlacik J, Statton B, Rabiner EA, Ye R, Veronese M, Hopkins SC, Koblan KS, Everall IP, Howes OD. PMID: 38942349 [PubMed - as supplied by publisher]
	Psychotic-like experiences in a nationally representative study of general population adolescents. Schizophr Res Lindgren M, Therman S. PMID: 38941725 [PubMed - as supplied by publisher]

Articles 1 - 20 / 63494

Page 1 of 3175



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy